Synthetic data: pharma’s next big thing?
Faster, better trials, enhanced pharmacoepidemiology and more ambitious cross-border research are just some of the likely use cases for synthetic data
Close log in window
Healthcare marketing is an industry more usually attuned to supporting the health of others, but with so many changes and pressures, we knew...
As clinical science continues to deliver on the promise of CGT, how can the industry make them available and affordable at scale?
Closer relationships with patients and a better understanding of what matters to them will show the way improving their experience of trials
There is a golden opportunity to deliver clinical trial innovation post-pandemic given healthcare’s appetite for new approaches, such as v...
